Analysis of drug permeation across Caco-2 monolayer: Implication for predicting in vivo drug absorption

Pharmaceutical Research

Volumn 14, Issue 4, 1997, Pages 486-491

  Yamashita, Shinji ^a   Tanaka, Yoshihiro ^a   Endoh, Yoriko ^a   Taki, Yoko ^a   Sakane, Toshiyasu ^a   Nadai, Tanekazu ^a   Sezaki, Hitoshi ^a  

^a SETSUNAN UNIVERSITY   (Japan)

Author keywords

Caco 2 monolayer; Drug lipophilicity; In vitro drug permeability; In vivo drug absorption; Intestinal membrane

Indexed keywords

CEFAZOLIN; PROPRANOLOL; SULFANILAMIDE; SULFANILIC ACID; SULFAPYRIDINE; WARFARIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STRAIN CACO 2; COLON; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG PENETRATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; JEJUNUM; LIPOPHILICITY; PRIORITY JOURNAL; RAT;

ANIMALS; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; COLON; HUMANS; INTESTINAL MUCOSA; JEJUNUM; PHARMACOKINETICS; RATS;

EID: 0030986812     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012103700981     Document Type: Article

References (20)

1. G. L. Amidon, P. J. Sinko, and D. Fleisher. Pharm. Res. 5:651-654 (1988).
2. P. J. Sinko, G. D. Lsseman, and G. L. Amidon. Pharm. Res. 8:979-988 (1991).
3. A. Zweibayn, M. Laburthe, E. Grasset, and D. Louvard. In S. G. Shultz, M. Field, R. A. Frizzell, and B. B. Bauner (Eds.) Handbook of Pgysiology, Section 6: The gastrointestinal system IV, Oxford University Press, New York, 1991, pp. 210-223.
4. A. R. Hilgers, R. A. Conradi, and P. S. Burton. Pharm. Res. 7:902-910 (1990).
5. G. Wilson, I. F. Hassan, C. J. Dix, I. Williamson, R. Shah, M. Mackay, and P. Artursson. J. Controlled Release 11:25-40 (1990).
6. K. M. Hillgresn, A. Kato, and R. T. Borchardt. Med. Res. Rev. 15:83-109 (1995).
7. S. Yamashita, Y. Yamazaki, M. Masada, T. Nadai, T. Kimura, and H. Sezaki. J. Pharmacobio-Dyn. 9:368-374 (1986).
8. S. Yamashita, H. Saitoh, K. Nakanishi, M. Masada, T. Nadai, and T. Kimura. J. Pharm. Pharmacol. 39:621-626 (1986).
9. Y. Tanaka, Y. Yaki, T. Sakane, T. Nadai, H. Sezaki, and S. Yamashita. Pharm. Res. 12:523-527 (1995).
10. I. J. Hidalgo and R. T. Borchardt. Biochim. Biophys. Acta 1028:25-30 (1990).
11. T. Kimura, S. Yamashita, K. S. Kim, and H. Sezaki. J. Pharm. Dyn. 5:495-500 (1982).
12. S. Yamashita, M. Masada, T. Nadai, and T. Kimura. J. Pharm. Sci. 79:579-583 (1990).
13. D. W. Powell. Am. J. Physiol. 241:G275-288 (1981).
14. M. Hu, P. J. Sinko, A. L. De Meere, D. A. Jhonson, and G. L. Amidon. J. theor. Biol. 131:107-114 (1988).
15. T. Kimura, K. S. Kim, and H. Sezaki. J. Pharmacobio Dyn. 4:35-41 (1981).
16. A. W. Larhed and P. Artursson. Eur. J. Pharm. Sci. 3:171-181 (1995).
17. D. Winne. Naunyn-Schmiedeberg's Arch. Pharmacol. 307:265-274 (1979).
18. J. Karlsson, A. Wikman, and P. Artursson. Int. J. Pharm. 99:209-218 (1993).
19. J. S. Trier and J. L. Madara. In L. R. Jhonson (ed.). Physiology of the Gastrointestinal Tract, Raven Press, New York, 1981, pp. 925-961.
20. P. Artursson and J. Karlsson. Biochem. Biophys. Res. Comm. 175:880-885 (1991).